Chronic kidney disease G5D (under hemodialysis) CKDG5D, Hemodialysis
Conditions
Interventions
Hydrogen inhalation (250 mL/min) for 24 weeks during haemodialysis (3 times a week for approx. 4 hr/treatment).
D01.268.406
Sponsors
Shibuya Masaki
Sano Motoaki
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Patients who have been on maintenance haemodialysis (including haemodialysis and haemodiafiltration) for at least 3 months. (2) Patients who are at least 18 years of age at the time of consent . (3) Gender Not applicable. (4) Inpatient or outpatient Not applicable. (5) Patients who have been fully informed of the study and have given their voluntary written consent based on full understanding.
Exclusion criteria
Exclusion criteria: (1) Patients with a history of or complicated with malignant tumours. However, patients with a history of malignant tumours who are untreated and have not relapsed for more than 5 years at the time of obtaining consent may be included. (2) Patients complicated with unstable angina or non-compensated heart failure. (3) Patients complicated with cirrhosis or liver failure. (4) Patients who require oxygen inhalation during dialysis. (5) Patients with frequent hypotension during dialysis (6)Patients who are judged to be inappropriate as research subjects by the principal investigator (co-principal investigator).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Safety (adverse events) | — |
Secondary
| Measure | Time frame |
|---|---|
| Relationship between hydrogen dosage and hydrogen blood concentration, expiratory gas analysis and ABI/CAVI, effect on anemia, effect on fatigue | — |
Contacts
Public ContactMasaki Shibuya
Yamaguchi University Hospital
Outcome results
None listed